| 000 | 01647 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514070146.0 | ||
| 264 | 0 | _c20030718 | |
| 008 | 200307s 0 0 eng d | ||
| 022 | _a0003-4967 | ||
| 024 | 7 |
_a10.1136/ard.62.6.561 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZou, J | |
| 245 | 0 | 0 |
_aUp regulation of the production of tumour necrosis factor alpha and interferon gamma by T cells in ankylosing spondylitis during treatment with etanercept. _h[electronic resource] |
| 260 |
_bAnnals of the rheumatic diseases _cJun 2003 |
||
| 300 |
_a561-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xtherapeutic use |
| 650 | 0 | 4 |
_aInterferon-gamma _xbiosynthesis |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xtherapeutic use |
| 650 | 0 | 4 |
_aSpondylitis, Ankylosing _xdrug therapy |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xbiosynthesis |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 700 | 1 | _aRudwaleit, M | |
| 700 | 1 | _aBrandt, J | |
| 700 | 1 | _aThiel, A | |
| 700 | 1 | _aBraun, J | |
| 700 | 1 | _aSieper, J | |
| 773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 62 _gno. 6 _gp. 561-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/ard.62.6.561 _zAvailable from publisher's website |
| 999 |
_c12546101 _d12546101 |
||